WPI 844 (Glipizide Extended Release 5 mg)

Pill with imprint WPI 844 is Orange, Round and has been identified as Glipizide extended release 5 mg. It is supplied by Watson Laboratories, Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 844

Glipizide extended release

Imprint:

WPI 844

Strength:

5 mg

Color:

Orange

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Sulfonylureas

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Watson Laboratories, Inc.

Inactive Ingredients:

acetyltributyl citrate
hydroxyethyl cellulose (2000 mpa.s at 1%)
hydroxypropyl cellulose (type h)
lactose monohydrate
magnesium stearate
methacrylic acid - methyl methacrylate copolymer (1:1)
polyethylene glycol
FD&C Yellow No. 6
shellac
isopropyl alcohol
ferrosoferric oxide
butyl alcohol
propylene glycol
ammonia
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
68084-0111	Amerisource Health Services
10370-0190	Anchen Pharmaceuticals, Inc.
54569-5547	A-S Medication Solutions, LLC (repackager)
54868-5210	Physicians Total Care Inc. (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.